RBC Capital analyst Brian Abrahams maintained a Hold rating on Galapagos (NASDAQ:GLPG) on Wednesday, setting a price target of $127, which is approximately 2.80% above the present share price of $123.54.
Abrahams expects Galapagos to post earnings per share (EPS) of -$1.25 for the fourth quarter of 2020.
The current consensus among 9 TipRanks analysts is for a Hold rating of shares in Galapagos, with an average price target of $140.78.
The analysts price targets range from a high of $170 to a low of $103.51.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $131.82 million and a net profit of -$32.36 million. The company's market cap is $8.07 billion.
According to TipRanks.com, RBC Capital analyst Brian Abrahams is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 8.6% and a 49.29% success rate.
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.